These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 30913015

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Characterization of glucose metabolism in youth with vs. without cystic fibrosis liver disease: A pilot study.
    Socorro Rayas M, Hughan KS, Javaid R, Kelly A, Salehi M.
    J Clin Transl Endocrinol; 2022 Jun; 28():100296. PubMed ID: 35342717
    [Abstract] [Full Text] [Related]

  • 45. The association between body composition, leptin levels and glucose dysregulation in youth with cystic fibrosis.
    Granados A, Beach EA, Christiansen AJ, Patterson BW, Wallendorf M, Arbeláez AM.
    J Cyst Fibros; 2021 Sep; 20(5):796-802. PubMed ID: 34183284
    [Abstract] [Full Text] [Related]

  • 46. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
    Scully KJ, Sherwood JS, Martin K, Ruazol M, Marchetti P, Larkin M, Zheng H, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Wexler DJ, Putman MS.
    J Clin Endocrinol Metab; 2022 Mar 24; 107(4):e1444-e1454. PubMed ID: 34850006
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. HMGB1 Is Increased by CFTR Loss of Function, Is Lowered by Insulin, and Increases In Vivo at Onset of CFRD.
    Montanini L, Cirillo F, Smerieri A, Pisi G, Giardino I, d'Apolito M, Spaggiari C, Bernasconi S, Amarri S, Street ME.
    J Clin Endocrinol Metab; 2016 Mar 24; 101(3):1274-81. PubMed ID: 26760176
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
    Rakotoarisoa L, Weiss L, Lefebvre F, Porzio M, Renaud-Picard B, Ravoninjatovo B, Abely M, Danner-Boucher I, Dubois S, Troussier F, Prevotat A, Rault G, Kessler R, Kessler L.
    J Diabetes Complications; 2024 Apr 24; 38(4):108703. PubMed ID: 38430625
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis.
    Kirigin Biloš LS, Altabas V, Vukić Dugac A, Baretić M.
    Medicina (Kaunas); 2024 Mar 14; 60(3):. PubMed ID: 38541202
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Glucose intolerance in cystic fibrosis patients.
    Lanng S.
    Paediatr Respir Rev; 2001 Sep 14; 2(3):253-9. PubMed ID: 12052327
    [Abstract] [Full Text] [Related]

  • 60. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis.
    Rafii M, Chapman K, Stewart C, Kelly E, Hanna A, Wilson DC, Tullis E, Pencharz PB.
    Am J Clin Nutr; 2005 Feb 14; 81(2):421-6. PubMed ID: 15699230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.